Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
Johnson & Johnson pays big for Swiss biotech firm Actelion | Euronews
European pharma: CEO talent is the new measure of company calibre
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
J&J seals $30bn Actelion deal in push for rare disease drugs - Gulf Times
Actelion-Verkauf - Jean-Paul und Martine Clozel: Das 30-Milliarden-Paar
PDF) Profile: Jean-Paul Clozel | charlie schmidt - Academia.edu
Actelion Could Boost Takeover Price for Johnson & Johnson
Pharma – Johnson & Johnson lancera son OPA le 3 mars | Tribune de Genève
Actelion-Gründer erhalten Preis der Vereinigung Starkes Basel
Jean-Paul Clozel
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
Jean-Paul Clozel – mit Herzblut für Actelion - Rendez-vous - SRF
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Profile: Jean-Paul Clozel | Nature Biotechnology
Was plant das Ehepaar Clozel? | NZZ
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Actelion in $360M settlement - San Francisco Business Times
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
Actelion offers sweetener to stave off attacks - SWI swissinfo.ch
Clozel's CHF1bn Actelion Spin-Out Idorsia Awaits Janssen Buy-In :: Scrip
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Actelion - Wikipedia
Vor der Übernahme ein Rekordergebnis | Tages-Anzeiger
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Jean-Paul Clozel: «Idorsia steht nicht zum Verkauf» | Finanz und Wirtschaft
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
